List of insiders holdings for INCYTE CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | BAKER BIOTECH CAPITAL II GP LLC BAKER FELIX BAKER JULIAN 10% Owner |
2017-02-22 16:47:01 | 34,389,438 0 |
34,389,438 | Form 13D |
2 | 14159 capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner |
2017-02-22 16:47:01 | 34,389,438 0 |
34,389,438 | Form 13D |
3 | Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner |
2017-02-22 16:47:01 | 34,389,438 0 |
34,389,438 | Form 13D |
4 | Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner |
2017-02-22 16:47:01 | 34,389,438 0 |
34,389,438 | Form 13D |
5 | Baker / Tisch Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner |
2017-02-22 16:47:01 | 34,389,438 0 |
34,389,438 | Form 13D |
6 | Baker Biotech Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner |
2017-02-22 16:47:01 | 34,389,438 0 |
34,389,438 | Form 13D |
7 | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
2024-06-14 18:23:05 | 31,209,896 0 |
31,209,896 | Form 13D |
8 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
2025-07-02 17:23:26 | 559,963 28,220,991 |
28,780,954 | Form 4 |
9 | TISCH ANDREW H No longer 10% owner. |
2005-02-10 11:31:03 | 1,541,669 0 |
1,541,669 | Form 13G |
10 | TISCH THOMAS J No longer 10% owner. |
2004-08-13 15:58:35 | 117,592 1,416,661 |
1,534,253 | Form 4/A |
11 | TISCH JAMES S No longer 10% owner. |
2004-08-13 15:58:06 | 117,592 1,216,661 |
1,334,253 | Form 4/A |
12 | TISCH DANIEL R No longer 10% owner. |
2006-04-21 12:04:18 | 1,126,669 0 |
1,126,669 | Form 13G |
13 | WHITFIELD ROY A Director |
2014-01-17 16:19:51 | 662,832 0 |
662,832 | Form 5 |
14 | Hoppenot Herve Special Advisor to the CEO |
2025-07-16 16:01:26 | 517,146 0 |
517,146 | Form 4 |
15 | CAGNONI PABLO J President, R&D |
2025-07-16 16:05:57 | 318,117 0 |
318,117 | Form 4 |
16 | FRIEDMAN PAUL A Director |
2020-05-28 16:27:11 | 267,327 15,000 |
282,327 | Form 4 |
17 | Meury William Chief Executive Officer |
2025-07-02 16:40:30 | 269,404 0 |
269,404 | Form 4 |
18 | BROOKE PAUL A Director |
2020-04-02 17:01:14 | 221,911 40,000 |
261,911 | Form 4 |
19 | HASTINGS DAVID C Chief Financial Officer |
2014-06-06 18:47:53 | 227,470 0 |
227,470 | Form 4 |
20 | Stamoulis Christiana EVP & Chief Financial Officer |
2025-07-16 16:03:58 | 178,526 0 |
178,526 | Form 4 |
21 | SWAIN PAULA J EVP, Human Resources |
2025-07-16 16:04:38 | 137,031 0 |
137,031 | Form 4 |
22 | Issa Mohamed Khairie EVP, Head of US Oncology |
2025-07-17 16:04:17 | 126,910 0 |
126,910 | Form 4 |
23 | Wenqing Yao EVP, Head of Discovery Chem |
2021-07-07 17:54:42 | 113,629 0 |
113,629 | Form 4 |
24 | Stein Steven H EVP & Chief Medical Officer |
2025-07-23 15:56:25 | 102,886 0 |
102,886 | Form 4 |
25 | KELLER JOHN A Chief Business Officer |
2008-02-11 17:28:56 | 100,000 0 |
100,000 | Form 4 |
26 | Andrews Patricia S Chief Commercial Officer |
2012-01-23 16:43:17 | 100,000 0 |
100,000 | Form 4 |
27 | DE SCHUTTER RICHARD U Chairman |
2015-03-09 16:35:21 | 99,821 0 |
99,821 | Form 4 |
28 | Pasquale Maria E EVP & General Counsel |
2023-07-18 16:00:15 | 89,999 0 |
89,999 | Form 4 |
29 | Denton Sheila A. EVP & General Counsel |
2025-07-17 16:04:54 | 82,073 0 |
82,073 | Form 4 |
30 | SAXE JON S Director |
2004-04-01 14:08:05 | 80,000 0 |
80,000 | Form 4 |
31 | Dhanak Dashyant EVP & Chief Scientific Officer |
2023-07-18 16:00:18 | 75,864 0 |
75,864 | Form 4 |
32 | Daly James M EVP, Chief Commercial Officer |
2015-06-25 16:28:05 | 71,283 0 |
71,283 | Form 4 |
33 | METCALF BRIAN W Chief Drug Discovery Scientist |
2011-04-13 16:09:01 | 66,504 0 |
66,504 | Form 4 |
34 | ARIKO BARRY A Director |
2015-03-13 16:28:02 | 45,834 0 |
45,834 | Form 4 |
35 | Iyengar Vijay K EVP, GMAPPS |
2025-07-17 16:05:27 | 40,540 0 |
40,540 | Form 4 |
36 | Trotta Matteo EVP, GM, Dermatology US |
2025-07-17 16:03:41 | 40,011 0 |
40,011 | Form 4 |
37 | HURLEY SCOTT W VP/Corp Controller & Treasurer |
2005-01-27 12:58:59 | 40,000 0 |
40,000 | Form 4 |
38 | Dickinson Jonathan Elliott EVP, General Manager, Europe |
2024-09-16 13:24:17 | 36,390 0 |
36,390 | Form 4 |
39 | Flannelly Barry P EVP & General Manager US |
2025-07-17 16:06:01 | 35,149 0 |
35,149 | Form 4 |
40 | Huber Reid M EVP, Chief Scientific Officer |
2018-07-18 16:28:26 | 34,571 0 |
34,571 | Form 4 |
41 | FBB Associates Director 10% Owner |
2012-06-18 17:33:56 | 33,410 0 |
33,410 | Form 3 |
42 | BIENAIME JEAN JACQUES Director |
2025-06-12 16:30:12 | 30,057 0 |
30,057 | Form 4 |
43 | FOUSE JACQUALYN A Director |
2025-06-12 16:30:47 | 28,542 0 |
28,542 | Form 4 |
44 | Tray Thomas Principal Accounting Officer |
2025-07-16 16:03:23 | 27,675 0 |
27,675 | Form 4 |
45 | Clancy Paul J Director |
2025-07-02 16:45:50 | 22,950 0 |
22,950 | Form 4 |
46 | High Katherine A Director |
2025-06-12 16:29:41 | 22,557 0 |
22,557 | Form 4 |
47 | SCHRECK PATRICIA A EVP, General Counsel |
2011-05-11 16:17:53 | 22,276 0 |
22,276 | Form 4 |
48 | Siegel Eric H. EVP, General Counsel |
2017-09-15 16:28:33 | 21,053 0 |
21,053 | Form 4 |
49 | BRAWLEY OTIS W Director |
2025-06-12 16:31:17 | 20,468 0 |
20,468 | Form 4 |
50 | HARRIGAN EDMUND Director |
2025-07-02 16:44:01 | 20,319 0 |
20,319 | Form 4 |
51 | NIBLACK JOHN F Director |
2011-05-23 16:38:41 | 20,000 0 |
20,000 | Form 4 |
52 | Emmens Matthew Director |
2008-05-22 16:32:43 | 20,000 0 |
20,000 | Form 4 |
53 | CRAVES FRED B Director |
2005-06-03 09:43:51 | 20,000 0 |
20,000 | Form 4 |
54 | Levy Richard S EVP, Chief Drug Dev Officer |
2016-01-08 16:37:56 | 19,802 0 |
19,802 | Form 4 |
55 | DIXON WENDY L Director |
2022-04-04 16:00:32 | 17,768 0 |
17,768 | Form 4 |
56 | Schaffert Susanne Director |
2025-06-12 16:28:33 | 16,605 0 |
16,605 | Form 4 |
57 | Chardonnet Laurent Vice President and Treasurer |
2015-04-01 16:27:38 | 15,129 0 |
15,129 | Form 4 |
58 | FBB2 LLC Director 10% Owner |
2012-06-18 17:35:48 | 15,110 0 |
15,110 | Form 3 |
59 | Friedman Steven M. EVP, Biology & Preclinical Dev |
2010-05-20 16:11:55 | 15,000 0 |
15,000 | Form 4 |
60 | Morrissey Michael James EVP, Head of Tech. Operations |
2025-07-17 16:02:19 | 10,961 0 |
10,961 | Form 4 |
61 | GRYSKA DAVID W Executive Vice President, CFO |
2018-07-18 16:12:41 | 10,235 0 |
10,235 | Form 4 |
62 | Heeson Lee EVP, Head of Incyte Intl |
2025-07-17 16:02:58 | 6,577 0 |
6,577 | Form 4 |
63 | Trower Paul Principal Accounting Officer |
2022-01-21 16:37:50 | 3,250 0 |
3,250 | Form 4 |
64 | TISCH BONNIE J 10% Owner |
2004-01-16 16:57:59 | 0 0 |
0 | Form 4 |
65 | PLATINUM ASSET MANAGEMENT LTD 10% Owner |
2009-02-10 18:56:09 | 0 0 |
0 | Form 13G |
66 | DAMIAL FOUNDATION INC 10% Owner |
2004-02-13 19:51:28 | 0 0 |
0 | Form 4 |